Generex Biotechnology Corp - ESG Rating & Company Profile powered by AI
This ESG rating includes 17 UN SDGs including: 'Quality Education', 'Responsible Production & Consumption' and 'Partnerships for the Goals'. The Sustainability assessment for Generex Biotechnology Corp represents its transparency towards the United Nations SDGs. Comprehensive ESG assessment of Generex Biotechnology Corp can be accessed by registering for free.
Generex Biotechnology Corp in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| ... | ... | ... | |
| 2747 | Aphria Inc | 0.3 | Low |
| 2747 | Sichuan Languang Development Co Ltd | 0.3 | Low |
| 2749 | Generex Biotechnology Corp | 0.0 | Low |
| 2749 | Alpha Group Industries Inc | 0.0 | Low |
| 2749 | BNC Korea Co Ltd (Pre-Merger) | 0.0 | Low |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Generex Biotechnology Corp have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Generex Biotechnology Corp disclose current and historical energy intensity?
Sign up for free to unlockDoes Generex Biotechnology Corp report the average age of the workforce?
Sign up for free to unlockDoes Generex Biotechnology Corp reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Generex Biotechnology Corp disclose its ethnicity pay gap?
Sign up for free to unlockDoes Generex Biotechnology Corp disclose cybersecurity risks?
Sign up for free to unlockDoes Generex Biotechnology Corp offer flexible work?
Sign up for free to unlockDoes Generex Biotechnology Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Generex Biotechnology Corp disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Generex Biotechnology Corp conduct supply chain audits?
Sign up for free to unlockDoes Generex Biotechnology Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Generex Biotechnology Corp conduct 360 degree staff reviews?
Sign up for free to unlockDoes Generex Biotechnology Corp disclose the individual responsible for D&I?
Sign up for free to unlockDoes Generex Biotechnology Corp disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Generex Biotechnology Corp disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Generex Biotechnology Corp disclose water use targets?
Sign up for free to unlockDoes Generex Biotechnology Corp have careers partnerships with academic institutions?
Sign up for free to unlockDid Generex Biotechnology Corp have a product recall in the last two years?
Sign up for free to unlockDoes Generex Biotechnology Corp disclose incidents of discrimination?
Sign up for free to unlockDoes Generex Biotechnology Corp allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Generex Biotechnology Corp issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Generex Biotechnology Corp disclose parental leave metrics?
Sign up for free to unlockDoes Generex Biotechnology Corp disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Generex Biotechnology Corp disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Generex Biotechnology Corp disclose the pay ratio of women to men?
Sign up for free to unlockDoes Generex Biotechnology Corp support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Generex Biotechnology Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Generex Biotechnology Corp reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Generex Biotechnology Corp involved in embryonic stem cell research?
Sign up for free to unlockDoes Generex Biotechnology Corp disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Generex Biotechnology Corp disclose its waste policy?
Sign up for free to unlockDoes Generex Biotechnology Corp report according to TCFD requirements?
Sign up for free to unlockDoes Generex Biotechnology Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Generex Biotechnology Corp disclose energy use targets?
Sign up for free to unlockDoes Generex Biotechnology Corp disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Generex Biotechnology Corp have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Generex Biotechnology Corp
These potential risks are based on the size, segment and geographies of the company.
Generex Biotechnology Corporation, through its subsidiaries, engages in the administration of formulations of large molecule drugs to the oral cavity using a hand-held aerosol applicator in Canada and the United States. It offers Generex Oral-lyn, an oral insulin product. The company is also developing AE37, a synthetic peptide vaccine, which has completed Phase IIb clinical trial to stimulate a potent and specific immune response against tumors expressing the HER-2/neu oncogene in patients with breast cancer and prostate cancer. In addition, it develops, manufactures, and distributes rapid point-of-care in-vitro medical diagnostics for infectious diseases, such as human immunodeficiency virus, tuberculosis, malaria, hepatitis B, hepatitis C, syphilis, and others; and test kits and cassettes for testing infectious diseases, as well as Excellagen, a wound conforming gel. Further, the company is developing immunotherapeutic products and vaccines; and extracellular matrix hydrogel solution, a tissue engineered therapy for the treatment of Ulcerative Colitis. Additionally, it manufactures and sells foot and ankle surgical kits that include plates, screws, and tools; and distributes surgical supplies, orthopedic implants, artificial joints, and biologics, medical devices, and regenerative medicine products. It also serves as the general partner of the Management Services Organization. Generex Biotechnology Corporation was founded in 1983 and is headquartered in Miramar, Florida. On April 23, 2022, an involuntary petition for liquidation under Chapter 7 was filed against Generex Biotechnology Corporation in the U.S. Bankruptcy Court for the Southern District of Florida. On June 6, 2022, the involuntary petition was approved by the Court.